Jeil Pharma Holdings Inc banner

Jeil Pharma Holdings Inc
KRX:002620

Watchlist Manager
Jeil Pharma Holdings Inc Logo
Jeil Pharma Holdings Inc
KRX:002620
Watchlist
Price: 8 870 KRW -0.89% Market Closed
Market Cap: ₩141.7B

Jeil Pharma Holdings Inc
Investor Relations

Jeil Pharma Holdings, Inc. engages in the management of its subsidiaries. The company is headquartered in Seoul, Seoul. The firm provides antibiotics, anti-inflammatory painkillers, hepatitis remedies, duodenum ulcer treatments, anticancer drugs, tristimania drugs, gastritis drugs, stomach ulcer drugs, septicemia treatments, pollakisuria treatments, acute bronchitis remedies, hyperlipidemia treatments and others. The firm distributes its products within domestic market and to overseas markets.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Seung-Soo Han
Chairman of The Board and Chief Executive Officer
No Bio Available

Contacts

Address
SEOUL
Seoul
343, Sapyeong-daero, Seocho-gu
Contacts
+8225497451
www.jeilph.co.kr
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett